The Latest Trends in Peptides and Oligonucleotides
It is an exciting time to manufacture peptides and oligonucleotides, molecules used in countless medicines undergoing rapid change and growth. We’ve looked at some of the driving forces behind this development and why it benefits chemical manufacturers of these...
Octreotide acetate – a complex molecule for a complex disease
Throughout our lives, intricate mechanisms regulate our body’s growth. The length of our arms and legs, the size of our heads, and the alignment of our teeth and jaws all tend to match up. This seems to happen automatically, so few of us pause to wonder why. Yet...
Glucagon-like peptide 1 (GLP-1)
Glucagon-like peptide 1 (GLP-1) is a hormone that enhances insulin secretion and shares similarities with glucagon. GLP-1 has beneficial effects on the pancreas, brain, and stomach. It promotes insulin release, increases insulin-producing cells, reduces glucagon...
How can pharma and biotech benefit from strategic alliances?
A strategic alliance is an agreement between two businesses that have opted to pool their resources (such as manufacturing capabilities, knowledge, technologies, or risks) in order to work on a particular project that will benefit both parties and provide value. In...